We now have 110 patients in our registries (EULAR + Global). Approximately 70% are female, and 18% are over the age of 65.
A majority of patients were on conventional synthetic DMARDs prior to diagnosis (63%), almost half on biologics (45%); a quarter were on glucocorticoids, and a quarter on NSAIDS.
35% were hospitalized, and 5% are deceased.
Of the 22 individuals on HCQ, 7 have resolved COVID19 infection, 12 have unresolved infection, 3 unknown. There was 1 death.
4/8 of those hospitalized needed some type of supplemental oxygen or non-invasive/invasive ventilation